NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma

PHASE1,PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Prostate cancer treatment has greatly changed since the initiation of this trial and therefore we have stopped this trial to allow for further evaluation of the treatment landscape

Conditions

Prostate Cancer

Interventions

DRUG: NBTXR3 activated by IMRT only
DRUG: NBTXR3 activated by Brachytherapy & IMRT

Sponsor

Nanobiotix